Exact Therapeutics AS (OSL:EXTX) Pre-Tax Income : kr-48.38 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Exact Therapeutics AS's pretax income for the six months ended in Dec. 2023 was kr-25.58 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was kr-48.38 Mil. Exact Therapeutics AS's pretax margin was %.

Exact Therapeutics AS Pre-Tax Income Historical Data

The historical data trend for Exact Therapeutics AS's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Pre-Tax Income Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-14.83

-33.09

-58.59

-40.57

-48.38

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial						-22.39	-26.91	-13.66	-22.80	-25.58

Competitive Comparison of Exact Therapeutics AS's Pre-Tax Income

For the Biotechnology subindustry, Exact Therapeutics AS's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Therapeutics AS's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's Pre-Tax Income falls into.

Exact Therapeutics AS Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Exact Therapeutics AS's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-48.379	+	0	+	-0.086	+	0.945	+	-0.862
	=	-48.38

Exact Therapeutics AS's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-26.129	+	0	+	0.983	+	0.425	+	-0.862
	=	-25.58

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-48.38 Mil.

Exact Therapeutics AS (OSL:EXTX) Pre-Tax Income Explanation

Exact Therapeutics AS's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-25.583	/	0
	=	%

Exact Therapeutics AS Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines